Validation of the risk factors for primary control of early T-stage laryngeal, oropharyngeal, and hypopharyngeal squamous cell carcinoma by transoral surgery: a prospective observational study.


Journal

International journal of clinical oncology
ISSN: 1437-7772
Titre abrégé: Int J Clin Oncol
Pays: Japan
ID NLM: 9616295

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 24 05 2021
accepted: 13 07 2021
pubmed: 23 7 2021
medline: 21 10 2021
entrez: 22 7 2021
Statut: ppublish

Résumé

We had previously identified the following risk factors for insufficient control of early T-stage head and neck cancer by transoral surgery (TOS): (1) tumor thickness > 7 mm on enhanced computed tomography (CT), and (2) poor differentiation in pathological examination. We subsequently used a different patient cohort to validate the usefulness of these factors in determining the need for adaptation of TOS. A prospective observational study METHODS: Patients who received TOS as a definitive treatment between April 1, 2016 and September 30, 2020 were included. Primary control rates (by single TOS and TOS alone) in relation to the above-mentioned risk factors were calculated. Overall (O), recurrence-free (RF), and disease-free (DF) survival (S) outcomes were evaluated. A combination analysis based on the number of risk factors was also performed. Patients with tumor thickness > 7 mm had a 2.88-fold [95% confidence interval (CI) 1.01-8.51] higher risk of incomplete primary resection by single TOS, while patients who showed poor differentiation on pathological assessments had a 13.14-fold (95% CI 3.66-47.14) higher risk of insufficient primary control by TOS alone. The 3 year OS, RFS, and DFS rates were 99%, 83%, and 63%, respectively. Patients with both risk factors had a 93.00-fold (95% CI 4.99-1732.00) higher risk of incomplete primary control by TOS alone. Among patients with early-stage laryngeal, oropharyngeal, and hypopharyngeal squamous cell carcinoma, primary control by TOS alone may not be achieved in patients with both risk factors, that is, tumor thickness > 7 mm as measured by enhanced CT and poor differentiation on pathological examination.

Sections du résumé

BACKGROUND BACKGROUND
We had previously identified the following risk factors for insufficient control of early T-stage head and neck cancer by transoral surgery (TOS): (1) tumor thickness > 7 mm on enhanced computed tomography (CT), and (2) poor differentiation in pathological examination. We subsequently used a different patient cohort to validate the usefulness of these factors in determining the need for adaptation of TOS.
STUDY SETTING METHODS
A prospective observational study METHODS: Patients who received TOS as a definitive treatment between April 1, 2016 and September 30, 2020 were included. Primary control rates (by single TOS and TOS alone) in relation to the above-mentioned risk factors were calculated. Overall (O), recurrence-free (RF), and disease-free (DF) survival (S) outcomes were evaluated. A combination analysis based on the number of risk factors was also performed.
RESULTS RESULTS
Patients with tumor thickness > 7 mm had a 2.88-fold [95% confidence interval (CI) 1.01-8.51] higher risk of incomplete primary resection by single TOS, while patients who showed poor differentiation on pathological assessments had a 13.14-fold (95% CI 3.66-47.14) higher risk of insufficient primary control by TOS alone. The 3 year OS, RFS, and DFS rates were 99%, 83%, and 63%, respectively. Patients with both risk factors had a 93.00-fold (95% CI 4.99-1732.00) higher risk of incomplete primary control by TOS alone.
CONCLUSIONS CONCLUSIONS
Among patients with early-stage laryngeal, oropharyngeal, and hypopharyngeal squamous cell carcinoma, primary control by TOS alone may not be achieved in patients with both risk factors, that is, tumor thickness > 7 mm as measured by enhanced CT and poor differentiation on pathological examination.

Identifiants

pubmed: 34291368
doi: 10.1007/s10147-021-01992-y
pii: 10.1007/s10147-021-01992-y
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1995-2003

Subventions

Organisme : KAKENHI
ID : 21K09636
Organisme : FP7 Ideas: European Research Council
ID : SK2803

Informations de copyright

© 2021. Japan Society of Clinical Oncology.

Références

Nishimura G, Sano D, Yabuki K et al (2017) The second look procedure for transoral videolaryngoscopic surgery for T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer patients: protocol for a nonrandomized clinical trial. JMIR Res Protoc 6:e235
doi: 10.2196/resprot.8907
Nishimura G, Sano D, Arai Y et al (2019) A prospective clinical trial of the second-look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer. Cancer Med 8:7197–7206
doi: 10.1002/cam4.2588
Sobin L, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley-Liss, New York
Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours, 8th edn. Wiley-Liss, New York
Dammann F, Horger M, Mueller-Berg M et al (2005) Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. AJR Am J Roentgenol 184:1326–1331
doi: 10.2214/ajr.184.4.01841326
Watanabe A, Taniguchi M, Tsujie H et al (2008) The value of narrow band imaging endoscope for early head and neck cancers. Otolaryngol Head Neck Surg 138:446–451
doi: 10.1016/j.otohns.2007.12.034
Morita M, Saeki H, Ito S et al (2014) Surgical strategies for esophageal cancer associated with head and neck cancer. Surg Today 44:1603–1610
doi: 10.1007/s00595-013-0713-3
Weinstein GS, O’Malley BW Jr, Snyder W et al (2007) Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol 116:19–23
doi: 10.1177/000348940711600104
Fujita Y, Hiramatsu M, Kawai M et al (2008) Successful treatment for hypopharyngeal cancer in a patient with superficial esophageal cancer by endoscopic submucosal dissection. Endoscopy 40(Supplement 2):E189–E190
doi: 10.1055/s-2007-995570
Shiotani A, Tomifuji M, Araki K et al (2010) Videolaryngoscopic transoral en bloc resection of supraglottic and hypopharyngeal cancers using laparoscopic surgical instruments. Ann Otol Rhinol Laryngol 119:225–232
doi: 10.1177/000348941011900403
Okada K, Tsuchida T, Ishiyama A et al (2012) Endoscopic mucosal resection and endoscopic submucosal dissection for en bloc resection of superficial pharyngeal carcinomas. Endoscopy 44:556–564
doi: 10.1055/s-0032-1309720
Okami K, Ebisumoto K, Sakai A et al (2013) Transoral en bloc resection of superficial laryngeal and pharyngeal cancers. Head Neck 35:1162–1167
doi: 10.1002/hed.23094
Steiner W, Ambrosch P (2000) Endoscopic laser surgery of the upper aerodigestive tract. Thieme, New York, pp 33–115
Yamashita T, Tomifuji M, Araki K et al (2011) Endoscopic transoral oropharyngectomy using laparoscopic surgical instruments. Head Neck 33:1315–1321
doi: 10.1002/hed.21604
Clinical practice guideline. Japan Society of Clinical Oncology. http://www.jsco-cpg.jp/esophageal-cancer/ .
Tomifuji M, Imanishi Y, Araki K et al (2011) Tumor depth as a predictor of lymph node metastasis of supraglottic and hypopharyngeal cancers. Ann Surg Oncol 18:490–496
doi: 10.1245/s10434-010-1219-5
Taniguchi M, Watanabe A, Tsujie H et al (2011) Predictors of cervical lymph node involvement in patients with pharyngeal carcinoma undergoing endoscopic mucosal resection. Auris Nasus Larynx 38:710–717
doi: 10.1016/j.anl.2011.01.001
Yuan X, Hsueh C-Y, Zhang M et al. (2021) A nomogram for predicting occult lymph node metastasis in early hypopharyngeal cancer with cN0. Eur Arch Otorhinolaryngol (Online ahead of print)
Nishimura G, Sano D, Arai Y et al (2021) The incidence of newly diagnosed secondary cancer; Sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer. Int J Clin Oncol 26:59–65
doi: 10.1007/s10147-020-01779-7

Auteurs

Goshi Nishimura (G)

Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. gnishimu@yokohama-cu.ac.jp.

Daisuke Sano (D)

Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Yasuhiro Arai (Y)

Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Hideaki Takahashi (H)

Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Takashi Hatano (T)

Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Yosuke Kitani (Y)

Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Kentaro Takada (K)

Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Takashi Wada (T)

Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Yohei Hiiragi (Y)

Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Nobuhiko Oridate (N)

Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH